Healthcare Industry News:  AZOR 

Devices Orthopaedic Neurosurgery

 News Release - March 8, 2011

Mazor Robotics' SpineAssist(R) Purchased by University of California, Irvine Medical Center

MAZOR Strengthens Position as Leading Provider of Innovative Robotic Spine Surgery Systems with Addition of One of America’s Premier Robotic Surgical Centers

CAESAREA, Israel--(Healthcare Sales & Marketing Network)-- MAZOR Robotics Ltd. (TASE:MZOR.ta ), a developer of innovative surgical robots and complementary products, announced today that the University of California, Irvine Medical Center has purchased SpineAssist®, MAZOR Robotics’ surgical robotic system that enables surgeons to conduct minimally invasive and complex spine surgeries in a safe and accurate manner.

The UC Irvine Medical Center, renowned for adopting cutting-edge medical technologies, is a world leader in performing robot-assisted surgeries for a variety of medical conditions.

“UC Irvine is a leader in robotic surgery, and the addition of SpineAssist will dramatically enhance our comprehensive robotic offering by adding spinal procedures to our specialties,” said Ralph V. Clayman, M.D., dean, UC Irvine School of Medicine. “Robotic surgery offers significant technological benefits to surgical performance versus conventional surgery and the University's investment in these advanced robotic technologies underscores our commitment to clinical excellence and successful patient outcomes.”

SpineAssist is designed to guide the surgeon, who performs the procedure manually with the help of the robotic arm. The system has been scientifically proven to increase the accuracy of spinal implants and significantly lower rates of misplaced screws and neurological deficits. For patients, this translates to fewer complications and revisions; and the minimally invasive technique contributes to faster recovery, with less pain and scarring. Additionally, use of SpineAssist results in less radiation exposure for the patient, surgeon and entire OR team during surgery.

“The selection of SpineAssist by a world class institution such as UC Irvine validates the benefits our system provides and underscores the value it provides patients, surgeons and hospitals,” said Ori Hadomi, CEO of MAZOR Robotics. “Over the past two months, MAZOR has sold a number of SpineAssist systems to hospitals across Europe. We are currently expanding our US operations, as several other leading US hospitals and medical centers are looking to develop robotic spine programs.”

About UC Irvine Medical Center

Orange County’s only university hospital, UC Irvine Medical Center offers acute- and general-care services at its new, 482,000-square-foot UC Irvine Douglas Hospital and is home to the county’s only Level I trauma center, American College of Surgeons-verified regional burn center and National Cancer Institute-designated comprehensive cancer center. U.S. News & World Report has included UC Irvine for 10 consecutive years on its list of America’s Best Hospitals, giving special recognition to its urology, gynecology, and ear, nose & throat programs.


MAZOR Robotics (TASE:MZOR.ta ) is dedicated to the development and marketing of innovative surgical robots and complementing products that provide a safer surgical environment for patients, surgeons and OR staff. MAZOR’s flagship product, SpineAssist®, is a specifically designed surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. The system has been successfully used in the placement of thousands of implants in the US and Europe. Multiple peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability and clinical advantages of SpineAssist. For more information, please visit

Source: Mazor Robotics

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.